29 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... #Meningitis #Antibiotics ... #Antimicrobials ... InfectiousDiseases #Pharmacology ... #Management
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
Recommendations for specific antimicrobial ... #IDSA #Meningitis ... #Antibiotics #Antimicrobial ... InfectiousDiseases #Pharmacology ... #Management
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Parenteral Antimicrobial ... #Parenteral #IV ... #Antibiotics #Osteomyelitis ... #management #treatment ... #pharmacology #
Considerations for progression of disease while on antimicrobial therapy:
 - Source Control?
 - Wrong bug?
 -
disease while on antimicrobial ... #antibiotics #checklist ... #Differential # ... Diagnosis #Management ... #Antibiotics #Antimicrobials
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Enteric Illness: • Antimicrobial ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA - Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Children
Initial empirical therapy
 • Amoxicillin-clavulanate (45 mg/kg/day
IDSA - Antimicrobial ... bid) Risk for antibiotic ... #Antibiotics #Bacterial ... Rhinosinusitis #IDSA ... peds #pediatrics #management
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
• macrolide (if ... fluoroquinolone #IDSA ... Acquired #Pneumonia #Antibiotics ... Treatment #Regimen #Management ... #Guidelines #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... to 5 mg/kg/day IV ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... HumanPapillomavirus #IDSA ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology